HCAT
Health Catalyst Inc
NASDAQ: HCAT · HEALTHCARE · HEALTH INFORMATION SERVICES
$1.25
-1.57% today
Updated 2026-04-30
Market cap
$100.81M
P/E ratio
—
P/S ratio
0.32x
EPS (TTM)
$-2.55
Dividend yield
—
52W range
$1 – $5
Volume
0.8M
Health Catalyst Inc (HCAT) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$1.25
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$18.14
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.2B | $0.3B | $0.3B | $0.3B | $0.3B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -57.20%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.